Three independent discounted-cash-flow-style models value Bio-Rad Laboratories, Inc.Class A every trading day. 0 of 3 currently price BIO above its market price.
| Free Cash Flow model | $-142.63 |
| Excess Profit model | $27.21 |
| Residual Earnings model | $-31.73 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +0.4% |
| Net debt / EBITDA | 25.5× |
| Gross margin | +51.9% |
| Revenue CAGR | -4.0% |
| Cash conversion | 0.7× |
| Dividend yield | — |
| Buyback yield | +6.7% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open BIO in StockKitty